1. Pretargeted Nuclear Imaging and Radioimmunotherapy Based on the Inverse Electron-Demand Diels–Alder Reaction and Key Factors in the Pretargeted Synthetic Design
   Lin Qiu et al, 2019, Contrast Media & Molecular Imaging CrossRef
2. Preliminary efficacy of [90Y]DOTA-biotin-avidin radiotherapy against non-muscle invasive bladder cancer
   Alessandra Alì et al, 2023, European Journal of Nuclear Medicine and Molecular Imaging CrossRef
3. Advances in the Application of Radionuclide-Labeled HER2 Affibody for the Diagnosis and Treatment of Ovarian Cancer
   Xianwen Hu et al, 2022, Frontiers in Oncology CrossRef
4. Comparative Evaluation of Novel 177Lu-Labeled PNA Probes for Affibody-Mediated PNA-Based Pretargeting
   Hanna Tano et al, 2021, Cancers CrossRef
5. Comparative Preclinical Evaluation of HER2-Targeting ABD-Fused Affibody® Molecules 177Lu-ABY-271 and 177Lu-ABY-027: Impact of DOTA Position on ABD Domain
   Yongsheng Liu et al, 2021, Pharmaceutics CrossRef
6. Experimental Therapy of HER2-Expressing Xenografts Using the Second-Generation HER2-Targeting Affibody Molecule 188Re-ZHER2:41071
   Yongsheng Liu et al, 2022, Pharmaceutics CrossRef